placebo in the treatment of endometriosis-associated pelvic pain (EAPP). STUDY DESIGN:
This was a 12-week, randomized, double-blind, placebo-controlled, multicenter (n= 33)
study in Germany, Italy, and Ukraine of 198 women aged 18–45 years with laparoscopically
confirmed endometriosis and EAPP score≥ 30mm on a visual analog scale (VAS).
Dienogest 2mg or placebo was administered orally once daily. The primary efficacy variable …